May 29, 2019 / 03:00AM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Q4 FY '18-'19 Earnings Conference Call of Aurobindo Pharma Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Krishna Kiran, Investor Relations. Thank you, and over to you, sir.
Krishna Kiran - Aurobindo Pharma Limited - IR Officer
Thank you, Nashid. Good morning and a warm welcome to our fourth quarter and full year FY '19 earnings call. I am Krishna Kiran from Aurobindo Pharma Investor Relations. We hope you have received the Q4 financials and the press release that we have sent out yesterday. These are also available on our website.
With me, we have our senior management team, represented by Mr. N. Govindarajan, Managing Director; Sanjeev Dani, COO, Head Formulations; Mr. Santhanam Subramanian, CFO; Mr. Swami Iyer, CFO, Aurobindo Pharma USA. We will begin the call with summary highlights from the management, followed by an interactive Q&A session.
Please note that some of the matters we will discuss today are
Full Year 2019 Aurobindo Pharma Ltd Earnings Call Transcript
May 29, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers